Datamonitor has identified 10 launch products in Mitsubishi Tanabe’s product portfolio, which are expected to provide $802m in sales growth out to 2016.
Features and benefits
• Gain insight into Mitsubishi Tanabe's strategic outlook across the next 6 years
• Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source
Request a Sample for or Inquire before buying the report @
This analysis examines the historical and forecast performance for Mitsubishi Tanabe in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Major points covered in Table of Contents of this report include:
• EXECUTIVE SUMMARY
• STRATEGIC INSIGHT
• COMPANY INTRODUCTION
• SALES ANALYSIS
• PRODUCT ANALYSIS
• Tables and Figures
Explore Table of Contents available in the report Mitsubishi Tanabe Pharma Corp.: PharmaVitae Profile.